Recent scientific studies showed that the administration of Epimedium flavonoids improved learning and memory ability through the suppression of microglia and astrocyte activation, resulting in a decrease in the production of IL-1β and TNF-α in the hippocampus of an Alzheimer’s disease mouse model [16]. Here, IL1B is linked to early-onset autosomal dominant Alzheimer disease.